Incyte Corporation (INCY)

Biotechnology

INCY · NASDAQ NMS - GLOBAL MARKET · USD

New to investing? How to read this page →

$112.80

+0.04%

Watch Compare

𝕏 r/in

Weekly undervalued picks (like INCY)

Price · 1 year

Watch + Add to portfolio

Loading live analysis…

Loading analysis…

Intrinsic Investor is for research and education only. Not financial advice.

Key metrics

EPS

$6.41

ROE

30.8%

Gross margin

52.8%

Debt/Equity

0.70x

Revenue growth

20.9%

Incyte Corporation — company intelligence

Earnings surprises

Q2 2026$3.09 vs $2.14 est+44.1%

Q1 2026$1.81 vs $1.40 est+29.4%

Q4 2025$1.80 vs $1.97 est-8.5%

Q3 2025$2.26 vs $1.69 est+33.7%

Analyst consensus · 35 analysts

18 Buy17 Hold0 Sell

Updated Oct 6, 2026

Insider activity · 90 days

30 buys24 sellsnet +498,820 shares

Gardner David HSell 920 · Sep 22, 2026

CAGNONI PABLO JSell 13,985 · Sep 15, 2026

CAGNONI PABLO Jother 9,233 · Sep 15, 2026

Recent SEC filings

4 — Insider transaction reportOct 5, 2026

4 — Insider transaction reportOct 2, 2026

Latest news

Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva — Yahoo · 2w ago

INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill — Yahoo · 2w ago

FDA Approves Atebrioz (Zilurgisertib) For Fibrodysplasia Ossificans Progressiva In Adults & Pediatric Patients 12+ Years; Atebrioz Recommended Dosage 100mg Once Daily — Benzinga · 2w ago

Incyte (INCY) Stock Could Be 34% Above Fair Value After EADV Data — Yahoo · 2w ago

Incyte (INCY) Heads To EADV With New Skin Disease Trial Data — Yahoo · 2w ago

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen Stocks Learn Intrinsic Value Trading Signals Compare Stocks

Explore more

More in Biotechnology →More in Biotechnology →Stocks in US →Stocks on NASDAQ NMS - GLOBAL MARKET →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

AbbVie IncABBV Amgen IncAMGN Gilead Sciences, IncGILD Vertex Pharmaceuticals IncVRTX Moderna IncMRNA Regeneron Pharmaceuticals IncREGN

Weekly undervalued picks (like INCY)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.